RARE
Ultragenyx Pharmaceutical Inc.stockNASDAQ
Market OpenNov 19, 2026 9:50:39 AM EST
17.74USD+0.056%(+0.01)98,812
Pre-marketNov 19, 2026 9:17:30 AM EST
17.70USD-0.169%(-0.03)
RARE Financials
In Q3 FY 2026 (ended ), Ultragenyx Pharmaceutical Inc. (RARE) reported revenue of $173M, net income of −$118M, operating cash flow of −$43M, and assets of $1.19B (filed ).
Loading financial statements…